Cargando…
MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
Myeloproliferative neoplasms (MPNs) constitute a group of disorders identified by an overproduction of cells derived from myeloid lineage. The majority of MPNs have an identifiable driver mutation responsible for cytokine-independent proliferative signalling. The acquisition of coexisting mutations...
Autores principales: | Grabek, Julian, Straube, Jasmin, Bywater, Megan, Lane, Steven W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465511/ https://www.ncbi.nlm.nih.gov/pubmed/32823933 http://dx.doi.org/10.3390/cells9081901 |
Ejemplares similares
-
A knockout combination for MPN stem cells
por: Bywater, Megan, et al.
Publicado: (2020) -
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
por: Baumeister, Julian, et al.
Publicado: (2021) -
Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020) -
Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN
por: Zhang, Jin, et al.
Publicado: (2023) -
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
por: Kaifie, A., et al.
Publicado: (2016)